{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:19:11Z","timestamp":1777389551671,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbadis.2020.165662","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T04:37:54Z","timestamp":1578371874000},"page":"165662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment"],"prefix":"10.1016","volume":"1866","author":[{"given":"Cinzia","family":"Bragato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Carra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Blasevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Brix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Cotelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2020.165662_bb0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbadis.2020.165662_bb0010","series-title":"Acid Maltase Deficiency. New York","first-page":"1559","author":"Engel","year":"2004"},{"key":"10.1016\/j.bbadis.2020.165662_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.a.35662","article-title":"How to describe the clinical spectrum in Pompe disease?","volume":"161","author":"G\u00fcng\u00f6r","year":"2013","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2020.165662_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2020.165662_bb0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbadis.2020.165662_bb0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbadis.2020.165662_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpeds.2009.03.015","article-title":"Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease","volume":"155","author":"Chen","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late- onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/auto.2984","article-title":"Autophagy and lysosomes in Pompe disease","volume":"2","author":"Fukuda","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2020.165662_bb0050","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2020.165662_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-1-6","article-title":"Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts","volume":"1","author":"Cardone","year":"2008","journal-title":"Pathogenetics"},{"key":"10.1016\/j.bbadis.2020.165662_bb0060","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"Van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2020.165662_bb0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2020.165662_bb0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ncb0910-823","article-title":"Autophagy in mammalian development and differentiation","volume":"12","author":"Mizushima","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/cells8020183","article-title":"Autophagy as a therapeutic target to enhance aged muscle regeneration","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2020.165662_bb0080","first-page":"45","article-title":"Role of autophagy in the pathogenesis of Pompe disease","volume":"26","author":"Raben","year":"2007","journal-title":"Acta Myol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0085","first-page":"114","article-title":"New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond","volume":"1","author":"Kishnani","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"3","key":"10.1016\/j.bbadis.2020.165662_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566523219666190621113807","article-title":"Reduction of autophagic accumulation in Pompe disease mouse model following gene therapy","volume":"19","author":"McCall","year":"2019","journal-title":"Curr Gene Ther."},{"key":"10.1016\/j.bbadis.2020.165662_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.omtm.2019.01.006","article-title":"Intravenous injection of an AAV-PHP.B vector encoding human acid \u03b1-glucosidase rescues both muscle and CNS defects in murine Pompe disease","volume":"12","author":"Lim","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"12","key":"10.1016\/j.bbadis.2020.165662_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015239","article-title":"Fiber type conversion by PGC-1\u03b1 activates Lysosomal and Autophagosomal biogenesis in both unaffected and Pompe skeletal muscle","volume":"5","author":"Takikita","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2020.165662_bb0105","doi-asserted-by":"crossref","unstructured":"Martina JA, Diab HI, Lishu L, Jeong-A L, Patange S, Raben N, et al. The Nutrient-Responsive Transcription Factor TFE3, Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris. Sci Signal. 2014;7(309): ra9.","DOI":"10.1126\/scisignal.2004754"},{"key":"10.1016\/j.bbadis.2020.165662_bb0110","first-page":"3909","article-title":"Novel therapy for liver Cancer: direct Intraarterial injection of a potent inhibitor of ATP","volume":"62","author":"Geschwind","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2020.165662_bb0115","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2020.165662_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18632\/genesandcancer.9","article-title":"Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells","volume":"5","author":"Zhang","year":"2014","journal-title":"Genes & Cancer"},{"key":"10.1016\/j.bbadis.2020.165662_bb0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/tpj.2016.13","article-title":"Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer","volume":"17","author":"Graziano","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bbadis.2020.165662_bb0130","first-page":"923","article-title":"3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell lines","volume":"30","author":"Ganapathy-Kanniappan","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbadis.2020.165662_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10863-012-9411-x","article-title":"Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells","volume":"44","author":"Davidescu","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1996.0186","article-title":"Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites","volume":"329","author":"Tsai","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2020.165662_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","article-title":"Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase","volume":"173","author":"Ko","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2020.165662_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10863-007-9094-x","article-title":"Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers\u2019 most common phenotypes, the \u201cWarburg effect\u201d, i.e., elevated glycolysis in the presence of oxygen","volume":"39","author":"Pedersen","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10863-012-9418-3","article-title":"Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate","volume":"44","author":"Queiros","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343","author":"Halestrap","year":"1999","journal-title":"Biochem. J."},{"issue":"30","key":"10.1016\/j.bbadis.2020.165662_bb0165","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid \u03b1-Glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage dis. Type II","volume":"73","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2020.165662_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40478-018-0638-6","article-title":"Skeletal myopathy in Pompe disease: a failure of satellite cell activation?","volume":"6","author":"Hiniker","year":"2018","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.bbadis.2020.165662_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymeth.2014.12.004","article-title":"Autophagy in zebrafish","volume":"75","author":"Varga","year":"2015","journal-title":"Methods."},{"issue":"3","key":"10.1016\/j.bbadis.2020.165662_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells6030021","article-title":"Studying autophagy in Zebrafish","volume":"6","author":"Mathai","year":"2017","journal-title":"Cells."},{"issue":"2","key":"10.1016\/j.bbadis.2020.165662_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbpb.2008.11.004","article-title":"The hexokinase gene family in the zebrafish: structure, expression, functional and phylogenetic analysis","volume":"152","author":"Gonz\u00e1lez-Alvarez","year":"2009","journal-title":"Comp Biochem Physiol B Biochem Mol Biol."},{"issue":"11","key":"10.1016\/j.bbadis.2020.165662_bb0190","doi-asserted-by":"crossref","first-page":"R1036","DOI":"10.1152\/ajpregu.00516.2012","article-title":"Exhausting exercise and tissue-specific expression of monocarboxylate transporters in rainbow trout","volume":"304","author":"Omlin","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/79951","article-title":"Effective targeted gene \u2018knockdown\u2019 in zebrafish","volume":"26","author":"Nasevicius","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2020.165662_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the Zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbadis.2020.165662_bb0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4161\/auto.6.5.12092","article-title":"Analyzing autophagy in zebrafish","volume":"6","author":"He","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2020.165662_bb0210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbadis.2020.165662_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1016-8478(23)13053-6","article-title":"Novel vector system optimized for injecting in vitro-synthetized mRNA into zebrafish embryos","volume":"17","author":"Ro","year":"2004","journal-title":"Mol. Cells."},{"key":"10.1016\/j.bbadis.2020.165662_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10863-012-9419-2","article-title":"3-bromopyruvate: targets and outcomes","volume":"44","author":"Shoshan","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1242\/dev.123.1.399","article-title":"Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva","volume":"123","author":"Granato","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2020.165662_bb0230","doi-asserted-by":"crossref","unstructured":"Louzao MC, Espi\u00f1a B, Vieytes MR, Vega FV, Rubiolo JA, Baba O, et al. \u201dFluorescent glycogen\" formation with sensibility for in vivo and in vitro detection. Glycoconj J. 2008;25(6):503\u2013510.","DOI":"10.1007\/s10719-007-9075-7"},{"key":"10.1016\/j.bbadis.2020.165662_bb0235","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbadis.2020.165662_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/287847","article-title":"Fishing for nature\u2019s hits: establishment of the zebrafish as a model for screening antidiabetic natural products","volume":"2015","author":"Tabassum","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbadis.2020.165662_bb0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/bdra.20810","article-title":"Extracellular matrix and heart development","volume":"91","author":"Lockhart","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0250","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/GIM.0b013e3182142966","article-title":"Cardiovascular abnormalities in late onset Pompe disease and response to enzyme replacement therapy for the late onset treatment study investigators","volume":"13","author":"Forsha","year":"2011","journal-title":"Genet Med."},{"key":"10.1016\/j.bbadis.2020.165662_bb0255","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"Ravikumar","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2020.165662_bb0260","series-title":"Cell Death \u2013 Autophagy, Apoptosis and Necrosis. Rijeka: Croatia: INTECH Press","first-page":"83","article-title":"The role of autophagy and apoptosis during embryo development","author":"Agnello","year":"2015"},{"key":"10.1016\/j.bbadis.2020.165662_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygcen.2016.03.028","article-title":"The maternal control in the embryonic development of zebrafish","volume":"245","author":"Miccoli","year":"2017","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0270","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/cdd.2010.191","article-title":"The Beclin 1 network regulates autophagy and apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2020.165662_bb0275","doi-asserted-by":"crossref","unstructured":"Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell. Mol. Biol. Lett. 2016;21:29.","DOI":"10.1186\/s11658-016-0031-z"},{"key":"10.1016\/j.bbadis.2020.165662_bb0280","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1039\/C5MB00310E","article-title":"Next-generation analysis of gene expression regulation\u2013comparing the roles of synthesis and degradation","volume":"11","author":"McManus","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bbadis.2020.165662_bb0285","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/15548627.2017.1381804","article-title":"Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)","volume":"14","author":"Jiao","year":"2018","journal-title":"Autophagy."},{"key":"10.1016\/j.bbadis.2020.165662_bb0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng.2471","article-title":"MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors","volume":"45","author":"Birsoy","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2020.165662_bb0295","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jnr.23474","article-title":"3-Bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes","volume":"93","author":"Ehrke","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2020.165662_bb0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10863-016-9670-z","article-title":"The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside","volume":"48","author":"Azevedo-Silva","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10863-014-9577-5","article-title":"The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria","volume":"46","author":"Macchioni","year":"2014","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2020.165662_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-physiol-021014-071649","article-title":"Lysosomal physiology","volume":"77","author":"Xu","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2020.165662_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/dna.2016.3459","article-title":"Disruption of the gaa gene in zebrafish fails to generate the phenotype of classical Pompe disease","volume":"36","author":"Wu","year":"2017","journal-title":"DNA and Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920300016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920300016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:52:57Z","timestamp":1760417577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443920300016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0925443920300016"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.165662","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.165662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165662"}}